Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Calcium

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  4  Next»
    Study title: Chan JCM, Young RB, Mamunes P Calcium and phosphorus metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: Effects of 1,25 dihydroxyvitamin-D3. Eur J Pediatr 1983;140(2):182(A 242) Chan JCM, Young RB, Mamunes P Calcium and phosphorus metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: Effects of 1,25 dihydroxyvitamin-D3. Eur J Pediatr 1983;140(2):182(A 242)
    Active substance: CALCITRIOL
    Study summary document link (including results):
    View full study record
    Document reference: 23151
    Study title: Bonjour, J .P ., A.L. Carrie, S . Ferrari, H . Clavien, D. Slosman, G . Theintz, and R. Rizzoli, Calcium enriched foods and bone mass growth in prepubertal girls : A randomized, double –blind, placebo-controlled trial . J. Clin . Invest. 99:1287-1294; 1997.Bonjour, J .P ., A.L. Carrie, S . Ferrari, H . Clavien, D. Slosman, G . Theintz, and R. Rizzoli, Calcium enriched foods and bone mass growth in prepubertal girls : A randomized, double –blind, placebo-controlled trial . J. Clin . Invest. 99:1287-1294; 1997.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23166
    Study title: Bonjour, J .P ., T. Chevalley, P . Ammann, D . Slosman and R . Rizzoli . Gain in bone mineral mass in prepubertal girls 3,5 years after discontinuation of calcium supplementation : a follow-up study . Lancet 358 :1208-1212 ; 2001. Bonjour, J .P ., T. Chevalley, P . Ammann, D . Slosman and R . Rizzoli . Gain in bone mineral mass in prepubertal girls 3,5 years after discontinuation of calcium supplementation : a follow-up study . Lancet 358 :1208-1212 ; 2001.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23167
    Study title: Cameron MA, Paton LM, Nowson CA, et al. The effect of calcium supplementation on bone density in premenarcheal females: a co-twin approach. J Clin Endocrinol Metab 2004; 89: 4916-4922. Cameron MA, Paton LM, Nowson CA, et al. The effect of calcium supplementation on bone density in premenarcheal females: a co-twin approach. J Clin Endocrinol Metab 2004; 89: 4916-4922.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23171
    Study title: Cameron MA, Paton LM, Nowson CA, Margerison C, Frame M, Wark JD. The effect of calcium supplementation on bone density in premenarcheal females: a co-twin approach. J Clin Endocrinol Metab. 2004 Oct; 89(10):4916-22 Cameron MA, Paton LM, Nowson CA, Margerison C, Frame M, Wark JD. The effect of calcium supplementation on bone density in premenarcheal females: a co-twin approach. J Clin Endocrinol Metab. 2004 Oct; 89(10):4916-22
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23160
    Study title: Clark AG, Oner A, Ward G, Turner C, Rigden SP, Haycock GB, Chantler C. Safety and efficacy of calcium carbonate in children with chronic renal failure. Nephrol Dial Transplant. 1989; 4(6):539-44. Clark AG, Oner A, Ward G, Turner C, Rigden SP, Haycock GB, Chantler C. Safety and efficacy of calcium carbonate in children with chronic renal failure. Nephrol Dial Transplant. 1989; 4(6):539-44.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23153
    Study title: Dibba B, Prentice A, Ceesay M, Stirling DM, Cole TJ, Poskitt EM. Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low-calcium diet. Am J Clin Nutr. 2000 Feb; 71(2):544-9. Dibba B, Prentice A, Ceesay M, Stirling DM, Cole TJ, Poskitt EM. Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low-calcium diet. Am J Clin Nutr. 2000 Feb; 71(2):544-9.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23158
    Study title: Dodiuk-Gad RP, Rozen GS, Rennert G, Rennert HS, Ish-Shalom S. Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake. Am J Clin Nutr. 2005 Jan; 81(1):168-74 Dodiuk-Gad RP, Rozen GS, Rennert G, Rennert HS, Ish-Shalom S. Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake. Am J Clin Nutr. 2005 Jan; 81(1):168-74
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23161
    Study title: Efical 1000mg : Rapport d'expertise sur la documentation clinique - SERBERT JL - 01/1995Efical 1000mg : Rapport d'expertise sur la documentation clinique - SERBERT JL - 01/1995
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23170
    Study title: Iuliano-Burns S, Wang XF, Evans A, Bonjour JP, Seeman E. Skeletal benefits from calcium supplementation are limited in children with calcium intakes near 800 mg daily. Osteoporos Int. 2006 Dec;17(12):1794-800. Epub 2006 Sep 22Iuliano-Burns S, Wang XF, Evans A, Bonjour JP, Seeman E. Skeletal benefits from calcium supplementation are limited in children with calcium intakes near 800 mg daily. Osteoporos Int. 2006 Dec;17(12):1794-800. Epub 2006 Sep 22
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23165
    Study title: Lloyd T., M. B. Andon, N. Rollings, J. K, Martel, J. R. Landis, L. M. Demers, D . F. Eggli, K . Kieselhorst, H. E. Kulin: CALCIUM SUPPLEMENTATION AND BONE MINERAL DENSITY IN ADOLESCENT GIRLS:JAMA 270 (1993) 842-844Lloyd T., M. B. Andon, N. Rollings, J. K, Martel, J. R. Landis, L. M. Demers, D . F. Eggli, K . Kieselhorst, H. E. Kulin: CALCIUM SUPPLEMENTATION AND BONE MINERAL DENSITY IN ADOLESCENT GIRLS:JAMA 270 (1993) 842-844
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23168
    Study title: López-Jaramillo P, Delgado F, Jácome P, Terán E, Ruano C, Rivera J. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol. 1997 Aug; 90(2):162-7. López-Jaramillo P, Delgado F, Jácome P, Terán E, Ruano C, Rivera J. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol. 1997 Aug; 90(2):162-7.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23157
    Study title: Lorenzen JK, Mølgaard C, Michaelsen KF, Astrup A. Calcium supplementation for 1 y does not reduce body weight or fat mass in young girls. Am J Clin Nutr. 2006 Jan; 83(1):18-23 Lorenzen JK, Mølgaard C, Michaelsen KF, Astrup A. Calcium supplementation for 1 y does not reduce body weight or fat mass in young girls. Am J Clin Nutr. 2006 Jan; 83(1):18-23
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23164
    Study title: Miller JZ, Smith DL, Flora L, Peacock M, Johnston CC Jr. Calcium absorption in children estimated from single and double stable calcium isotope techniques. Clin Chim Acta. 1989 Aug 15; 183(2):107-13. Miller JZ, Smith DL, Flora L, Peacock M, Johnston CC Jr. Calcium absorption in children estimated from single and double stable calcium isotope techniques. Clin Chim Acta. 1989 Aug 15; 183(2):107-13.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23152
    Study title: Chan JCM, et al. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics 1983;72:225-233Chan JCM, et al. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics 1983;72:225-233
    Active substance: CAPSAICIN
    Study summary document link (including results):
    View full study record
    Document reference: 23221
    Study title: NATIONAL INSTITUTES OF HEALTH- CONSENSUS DEVELOPMENT CONFERENCE STATEMENT : OPTIMAL CALCIUM INTAKE: June 6.-8.1994, Bethesda/MDNATIONAL INSTITUTES OF HEALTH- CONSENSUS DEVELOPMENT CONFERENCE STATEMENT : OPTIMAL CALCIUM INTAKE: June 6.-8.1994, Bethesda/MD
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23169
    Study title: Prentice A, Ginty F, Stear SJ, Jones SC, Laskey MA, Cole TJ. Calcium supplementation increases stature and bone mineral mass of 16- to 18-year-old boys. J Clin Endocrinol Metab. 2005 Jun; 90(6):3153-61. Epub 2005 Mar 8. Prentice A, Ginty F, Stear SJ, Jones SC, Laskey MA, Cole TJ. Calcium supplementation increases stature and bone mineral mass of 16- to 18-year-old boys. J Clin Endocrinol Metab. 2005 Jun; 90(6):3153-61. Epub 2005 Mar 8.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23162
    Study title: Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005 Aug; 16(8):2501-8. Epub 2005 Jun 8. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005 Aug; 16(8):2501-8. Epub 2005 Jun 8.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23163
    Study title: Stear SJ, Prentice A, Jones SC, Cole TJ. Effect of a calcium and exercise intervention on the bone mineral status of 16-18-y-old adolescent girls. Am J Clin Nutr. 2003 Apr; 77(4):985-92. Stear SJ, Prentice A, Jones SC, Cole TJ. Effect of a calcium and exercise intervention on the bone mineral status of 16-18-y-old adolescent girls. Am J Clin Nutr. 2003 Apr; 77(4):985-92.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23159
    Study title: Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol. 1990 Oct; 163(4 Pt 1):1124-31. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol. 1990 Oct; 163(4 Pt 1):1124-31.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23154
    1  2  3  4  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Jun 12 00:30:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA